Novarum eyes further growth after 78 per cent revenue surge
Smartphone specialist Novarum is boosting its team with six new members after revenue surged by 78 per cent in 2015/16.
Headquartered in Edinburgh, the business is on course to continue this strong growth trajectory over the next 12 months.
Its team team has increased by 50 per cent in the last quarter and the appointment of four further members of staff is scheduled for the near future.
Dr Neil Polwart, Novarum Founder and BBI Group Head of Mobile, said: “Novarum has experienced a fantastic period of growth over the last 18 months and we’re very pleased to be expanding the team.
“We’re beginning to witness a surge in demand for mobile technology – particularly from diagnostic companies, and we look forward to the enhanced capability that our new team members will enable Novarum to deliver.”
Its smartphone solutions allow users to read and share results of diagnostic tests using nothing more than a smartphone.
The technology can be used by anyone, to connect with medical professionals or field-workers with minimal user-training.
Following the acquisition from BBI Group in October 2016, Novarum now has access to diagnostics knowledge and expertise over 450 strong.
The acquisition enabled both companies to support a wider range of customers by bringing the benefits of smartphone reader connectivity, accuracy and convenience to the marketplace.
Its innovative smartphone reader technology facilitates the reading and sharing of diagnostic test results with multiple applications across the medical, food safety, veterinary and aviation industries, with no extra hardware, and at a low total cost of ownership.
Novarum has appointed a new customer relations manager, and is now appointing key roles across the business, including commercial, quality assurance and software engineers for web and mobile development.
The company’s smartphone readers enable tests to be accurately read on-site, in remote and challenging environments, with the results shared securely with healthcare professionals or specific end-users.